Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK2 | Q05397 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12547683 | 0.71 | MEN1 (0.35) | MEN1KMT2ATDP1 | |
| SCHEMBL12340277 | 0.70 | — | — | |
| SCHEMBL10254578 | 0.67 | — | — | |
| SCHEMBL10020740 | 0.67 | AHR (0.35) | — | |
| SCHEMBL6124793 | 0.65 | TDP1 (0.43) | PTK2MEN1KMT2ATDP1 | |
| SCHEMBL107641 | 0.64 | PTK2 (1.00) | PTK2MEN1KMT2ATDP1 | |
| SCHEMBL1911468 | 0.63 | NOS3 (0.35) | KMT2A | |
| SCHEMBL12197393 | 0.61 | USP8 (0.31) | — | |
| Hydrochloric Acid SCHEMBL208784 | 0.60 | PTK2 (0.89) | PTK2MEN1KMT2ATDP1 | |
| SCHEMBL29614551 | 0.60 | PTK2 (0.89) | PTK2MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120101243-A1 | SUBSTITUTED BENZAZOLOPORPHYRAZINES FOR POLYMERIZATION AND SURFACE ATTACHMENT AND ARTICLES FORMED THEREFROM | UNITED STATES DEPARTMENT OF ENERGY | 2012-04-26 | — | — | US | disclosed |
| US-8106393-B2 | Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-01-31 | — | — | US | disclosed |
| US-20120004384-A1 | SUBSTITUTED BENZAZOLOPORPHYRAZINES FOR POLYMERIZATION AND SURFACE ATTACHMENT AND ARTICLES FORMED THEREFROM | UNITED STATES DEPARTMENT OF ENERGY | 2012-01-05 | — | — | US | disclosed |
| US-7994423-B2 | Charge-transport materials, methods of fabrication thereof, and methods of use thereof | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-08-09 | — | — | US | disclosed |
| US-7919770-B2 | Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom | NORTH CAROLINA STATE UNIVERSITY (US) | 2011-04-05 | — | — | US | disclosed |
| US-20110015388-A1 | Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom | UNITED STATES DEPARTMENT OF ENERGY | 2011-01-20 | — | — | US | disclosed |
| US-20090065057-A1 | Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | GEORGIA TECH RESEARCH CORPORATION | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090065057-A1 | Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | SLC9A3, SLC18A2, SLC9A2 | PTK2 1963/4885MEN1 1440/4885KMT2A 3138/4885 |
| US-20120004384-A1 | SUBSTITUTED BENZAZOLOPORPHYRAZINES FOR POLYMERIZATION AND SURFACE ATTACHMENT AND ARTICLES FORMED THEREFROM | PNMT, HNMT, COMT | PTK2 171/4885MEN1 4506/4885KMT2A 583/4885 |
| US-20120101243-A1 | SUBSTITUTED BENZAZOLOPORPHYRAZINES FOR POLYMERIZATION AND SURFACE ATTACHMENT AND ARTICLES FORMED THEREFROM | PNMT, HNMT, COMT | PTK2 171/4885MEN1 4506/4885KMT2A 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.